<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>diabetic retinopathy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/diabetic-retinopathy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 17:33:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>diabetic retinopathy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ANGPTL3-Integrin α5 Link Fuels Diabetic Retinopathy Leakage</title>
		<link>https://bioengineer.org/angptl3-integrin-%ce%b15-link-fuels-diabetic-retinopathy-leakage/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 17:32:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ANGPTL3-integrin α5 axis]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Diabetic Retinopathy]]></category>
		<category><![CDATA[Molecular Pathways]]></category>
		<category><![CDATA[Molecular Pathways** **Açıklama:** 1. **Diabetic Retinopathy:** Makalenin ana konusu ve araştırmanın odaklandığı hastalık. 2. **ANGPTL3-integrin α]]></category>
		<category><![CDATA[Retinal Vascular Leakage]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<category><![CDATA[therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/angptl3-integrin-%ce%b15-link-fuels-diabetic-retinopathy-leakage/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have unveiled the crucial role of the ANGPTL3-integrin α5 axis in driving retinal vascular leakage, a key feature of diabetic retinopathy (DR). This condition, which affects millions worldwide, is a leading cause of vision loss among diabetes patients. The team, led by Dr. Jing Ke, examined how alterations in this [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318454</post-id>	</item>
		<item>
		<title>IL-6 Trans-Signaling: Key Driver of Retinal Neovascularization?</title>
		<link>https://bioengineer.org/il-6-trans-signaling-key-driver-of-retinal-neovascularization/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 12:37:43 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Angiogenesis therapy** **Kısa açıklama:** 1. **IL-6 trans-signaling:** Makalenin ana konusu ve araştırmanın temel odağı. 2. **Retinal neovascularization:** Çalışmanın incelediği pat]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **IL-6 trans-signaling]]></category>
		<category><![CDATA[IL-6 trans-signaling]]></category>
		<category><![CDATA[ocular inflammation]]></category>
		<category><![CDATA[retinal neovascularization]]></category>
		<category><![CDATA[targeted therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/il-6-trans-signaling-key-driver-of-retinal-neovascularization/</guid>

					<description><![CDATA[In the realm of retinal research, a groundbreaking study has emerged that highlights the intricate relationship between IL-6 trans-signaling and retinal neovascularization. This study, conducted by a team of researchers led by Jung et al., sheds light on a critical but often overlooked factor in the pathology of retinal diseases. Retinal neovascularization is a complex [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318323</post-id>	</item>
		<item>
		<title>Cystatin C: A Key Biomarker for Diabetic Complications</title>
		<link>https://bioengineer.org/cystatin-c-a-key-biomarker-for-diabetic-complications/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 00:43:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[Cystatin C]]></category>
		<category><![CDATA[Cystatin C biyobelirteç]]></category>
		<category><![CDATA[Diabetic Complications]]></category>
		<category><![CDATA[Diabetic kidney disease]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Diyabet komplikasyonları **Açıklama:** Bu etiketler]]></category>
		<category><![CDATA[Diyabetik böbrek hastalığı]]></category>
		<category><![CDATA[Diyabetik retinopati]]></category>
		<category><![CDATA[erken teşhis]]></category>
		<category><![CDATA[metnin ana konularını kapsayacak şekilde seçilmiştir: 1. **Cystatin C biyobelirteç:** Makalenin ana kon]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cystatin-c-a-key-biomarker-for-diabetic-complications/</guid>

					<description><![CDATA[In recent years, the medical community has been delving deeper into the intricate relationship between diabetes and various health complications. Among the most pressing concerns is diabetic retinopathy, a serious condition that can result in vision loss and is often seen as a complication of diabetes. The correlation between diabetes and diabetic kidney disease is [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316329</post-id>	</item>
		<item>
		<title>New Biomarkers Unveiled in Diabetic Retinopathy Research</title>
		<link>https://bioengineer.org/new-biomarkers-unveiled-in-diabetic-retinopathy-research/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 30 Dec 2025 18:20:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Macrophage polarization]]></category>
		<category><![CDATA[Mitochondrial biomarkers]]></category>
		<category><![CDATA[Retinal inflammation]]></category>
		<category><![CDATA[therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-biomarkers-unveiled-in-diabetic-retinopathy-research/</guid>

					<description><![CDATA[In a groundbreaking commentary published in the Journal of Translational Medicine, researchers Deng and Xu examined the intricate connection between macrophage polarization and mitochondrial-related biomarkers in diabetic retinopathy (DR). This form of eye disease, a prevalent complication of diabetes mellitus, represents a significant challenge in clinical ophthalmology due to its potential to lead to severe [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312444</post-id>	</item>
		<item>
		<title>Endothelial Activation Links Stress Index to Diabetic Retinopathy</title>
		<link>https://bioengineer.org/endothelial-activation-links-stress-index-to-diabetic-retinopathy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 26 Nov 2025 09:22:30 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetic kidney disease]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Endothelial activation]]></category>
		<category><![CDATA[NHANES database]]></category>
		<category><![CDATA[Stress index]]></category>
		<guid isPermaLink="false">https://bioengineer.org/endothelial-activation-links-stress-index-to-diabetic-retinopathy/</guid>

					<description><![CDATA[Recent advancements in medical research have highlighted critical connections between endothelial activation and various health complications, particularly among patients suffering from diabetic kidney disease. A compelling study released by Liu, Yan, Wang, and colleagues delved into these intricacies, revealing alarming associations with stress indices and the onset of diabetic retinopathy. This cross-sectional analysis, grounded in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">301518</post-id>	</item>
		<item>
		<title>Proteome Atlas Unveils Diabetic Retinopathy Risks</title>
		<link>https://bioengineer.org/proteome-atlas-unveils-diabetic-retinopathy-risks/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 31 Oct 2025 21:26:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[proteome atlas]]></category>
		<category><![CDATA[risk prediction]]></category>
		<guid isPermaLink="false">https://bioengineer.org/proteome-atlas-unveils-diabetic-retinopathy-risks/</guid>

					<description><![CDATA[In a groundbreaking study that promises to reshape our understanding of diabetic retinopathy, researchers have unveiled an unprecedented proteome atlas that maps the intricate molecular landscape of this debilitating retinal disease. Published recently in Nature Communications, this work represents a paradigm shift in both the mechanistic insights and predictive capabilities regarding diabetic retinopathy, a leading [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">289925</post-id>	</item>
	</channel>
</rss>
